Ph.D., Boston University School of Medicine, 2003
firstname.lastname@example.org | (516) 367-5223 (p)
I study a type of brain cancer known as malignant glioma, which differs from healthy tissue by a small number of defining characteristics. By forcing glioma cells to adopt these healthy traits, we can stop tumor growth. My group searches for therapeutic ways to force this transition.
Hongwu Zheng’s lab aims to define the complex biology of malignant glioma pathogenesis, with the ultimate goal of translating the developed knowledge into patient benefits. Although eerily similar in terms of their self-renewal capacity and distinct phenotypic plasticity, malignant glioma cells conspicuously lack the terminal differentiation traits possessed by their normal counterparts—neural progenitors. With the use of multiple approaches combining human cancer genomics, animal modeling, and stem cell biology, Zheng has unraveled the causal relationship between aberrant differentiation and ensuing gliomagenesis. Perhaps more importantly, his team has demonstrated that forced restoration of differentiation capacity within glioma cells can drastically attenuate their tumorigenic potential. This finding fits well with the team’s overall strategy, which is to target differentiation control pathways as a novel avenue for malignant glioma treatment. To this end, they have sought (1) to develop various animal models to recapitulate the human glioma pathogenesis and utilize them to trace and investigate in vivo tumor initiation/ progression and (2) to identify key pathways/players controlling normal and neoplastic neural progenitor cell renewal and fate determination.
Zheng, H. W. and Ying, H. Q. and Wiedemeyer, R. and Yan, H. Y. and Quayle, S. N. and Ivanova, E. V. and Paik, J. H. and Zhang, H. L. and Xiao, Y. H. and Perry, S. R. and Hu, J. and Vinjamoori, A. and Gan, B. Y. and Sahin, E. and Chheda, M. G. and Brennan, C. and Wang, Y. A. and Hahn, W. C. and Chin, L. and DePinho, R. A. (2010) PLAGL2 Regulates Wnt Signaling to Impede Differentiation in Neural Stem Cells and Gliomas. Cancer Cell, 17(5) pp. 497-509.
Ying, H. Q. and Zheng, H. W. and Scott, K. and Wiedemeyer, R. and Yan, H. Y. and Lim, C. and Huang, J. and Dhakal, S. and Ivanova, E. and Xiao, Y. H. and Zhang, H. L. and Hu, J. and Stommel, J. M. and Lee, M. A. and Chen, A. J. and Paik, J. H. and Segatto, O. and Brennan, C. and Elferink, L. A. and Wang, Y. A. and Chin, L. and DePinho, R. A. (2010) Mig-6 controls EGFR trafficking and suppresses gliomagenesis. Proceedings of the National Academy of Sciences of the United States of America, 107(15) pp. 6912-6917.
Zheng, H. W. and Ying, H. Q. and Yan, H. Y. and Kimmelman, A. C. and Hiller, D. J. and Chen, A. J. and Perry, S. R. and Tonon, G. and Chu, G. C. and Ding, Z. H. and Stommel, J. M. and Dunn, K. L. and Wiedemeyer, R. and You, M. J. J. and Brennan, C. and Wang, Y. A. and Ligon, K. L. and Wong, W. H. and Chin, L. and DePinho, R. A. (2008) p53 and Pten control neural and glioma stem/progenitor cell renewal and differentiation. Nature, 455(7216) pp. 1129-U13.
Zheng, H. and Ying, H. and Yan, H. and Kimmelman, A. C. and Hiller, D. J. and Chen, A. J. and Perry, S. R. and Tonon, G. and Chu, G. C. and Ding, Z. and Stommel, J. M. and Dunn, K. L. and Wiedemeyer, R. and You, M. J. and Brennan, C. and Wang, Y. A. and Ligon, K. L. and Wong, W. H. and Chin, L. and dePinho, R. A. (2008) Pten and p53 converge on c-Myc to control differentiation, self-renewal, and transformation of normal and neoplastic stem cells in glioblastoma. Cold Spring Harbor Symposia on Quantitative Biology, 73 pp. 427-37.
Zheng, H. W. and You, H. and Zhou, X. Z. and Murray, S. A. and Uchida, T. and Wulf, G. and Gu, L. and Tang, X. R. and Lu, K. P. and Xiao, Z. X. J. (2002) The prolyl isomerase Pin1 is a regulator of p53 in genotoxic response. Nature, 419(6909) pp. 849-853.Additional materials of the author at
CSHL Institutional Repository